M&A and Strategic Advisory firm Stenvall Skoeld & Company
  • About Us
    • Leadership
    • Locations
  • Services
    • Mergers & Acquisitions
      • Buy Side M&A Advisory
      • Sell Side M&A Advisory
    • Strategic Advisory & Research
  • Industries
    • Chemicals and Basic Materials
    • Consumer and Retail
    • Energy and Environment
    • Food and Agribusiness
    • Healthcare
    • Industrials
    • Technology, Media and Telecom
  • Careers
  • Contact
Select Page

China M&A – Week in Review – 2-8 NOV 2015

by Carl-Johan Skoeld | Nov 9, 2015 | China M&A, China Outbound M&A, General

China M&A Week in Review is SSCO’s weekly summary of deals and key developments in China related Mergers and Acquisitions. Our emphasis is on cross-border deals. This Week’s Links M&A Trends China lifts IPO ban as stock market returns to health –...

China M&A – Week in Review – 24-28 AUG 2015

by Carl-Johan Skoeld | Aug 29, 2015 | China M&A, China Outbound M&A, General

China M&A Week in Review is SSCO’s weekly summary of deals and key developments in China related Mergers and Acquisitions. Our emphasis is on cross-border deals. M&A Trends Inbound M&A Outbound M&A and Investment Domestic M&A M&A Trends...

China M&A – Week in Review – 17-21 AUG 2015

by Carl-Johan Skoeld | Aug 24, 2015 | China M&A, China Outbound M&A, General

China M&A Week in Review is SSCO’s weekly summary of deals and key developments in China related Mergers and Acquisitions. Our emphasis is on cross-border deals. M&A Trends Inbound M&A Outbound M&A and Investment Domestic M&A   M&A Trends...
Q&A: Improving Wound Care in China

Q&A: Improving Wound Care in China

by Carl-Johan Skoeld | Apr 28, 2014 | General, Healthcare, SSCO Newsletters

This post was originally published in the September 2013 issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. Improving wound...
Q&A: Competitive impact of China’s new GMP rules

Q&A: Competitive impact of China’s new GMP rules

by Carl-Johan Skoeld | Apr 24, 2014 | China M&A, General, Healthcare, SSCO Newsletters

This post was originally published in February 2014 issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. Competitive impact of...
Q&A: Competitive impact of China’s new GMP rules

M&A and privatization of public Chinese hospitals

by Carl-Johan Skoeld | Mar 6, 2014 | China M&A, General, Healthcare, SSCO Newsletters

This post was originally published in February 2014 issue of our healthcare newsletter China Healthcare Deals+Strategies. Subscribe (email) to our newsletter to learn more about our perspectives and insights on China’s healthcare sector. M&A and...
« Older Entries
  • Services
    • Mergers & Acquisitions
    • Buy Side M&A Advisory
    • Sell Side M&A Advisory
    • Capital Raising
    • Strategy & Research
  • Industries
    • Chemicals
    • Consumer and Retail
    • Energy and Environment
    • Food and Agribusiness
    • Healthcare
    • Industrials
    • TMT

SSCO Shanghai Head Office



Stenvall Skoeld & Company (China) Limited
4th Floor 139 No. 1 Ruijin Road
Huangpu District, Shanghai

Tel: +86 (21) 6136 6008
  • English
  • 中文
© Copyright 2021 Stenvall Skoeld & Company